According to the Centers for Disease Control (CDC) and Prevention there are 3 million people that are affected by bleeding disorders. Some bleeding disorders are inherited such as Hemophilia A & B and von Willebrand disease (VWD). The primary symptom of Hemophilia is uncontrolled spontaneous bleeding. von Willebrand disease is the most common bleeding disorder, caused by a deficient or defective blood protein. It is difficult for doctors to assist people with certain bleeding disorders because they affect a person’s ability to form a clot which can lead to rapid and excessive blood loss and may increase their risk of death. These patients often suffer from uncontrollable bleeding after an injury, trauma, or surgery, get frequent nosebleeds, bruise easily, and can even suffer from spontaneous bleeding.
March is bleeding disorder awareness month. Organizations like the National Hemophilia Foundation (NHF) partner with the CDC to develop treatments and hopefully one day find a cure. Learn more about the Red Thread Campaign to see how you can get involved.
Hemostatic agents offer an effective tool to stop excessive bleeding. Hemostats that work independent of the body’s natural clotting cascade may offer benefits to patients with impaired coagulation. Visit our About Page to find out how our hemostats work through the absorption of fluid in the blood to create a robust mechanical gel-like clot.
SOURCE: National Hemophilia Foundation
Related Links
http://www.hemophilia.org
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
Please leave us your details as below and submit or send us an e-mail to: info@omni-stat.com
This website uses Cookies to improve your browsing experience. View Cookies Policy
I'm fine with this